Skip to content
Free shipping  ·  Cancel anytime  ·  Licensed US clinicians in all 50 states
Womea
Blog

Menopause and heart health: what changes and how to protect yourself

Heart disease is the leading cause of death in women, and risk shifts during menopause. Here is what changes, what the trials say about hormone therapy and the heart, and how to protect yourself.

June 14, 20268 min readMedically reviewed by Sean Arora, MD

Menopause raises cardiovascular risk: falling estrogen worsens cholesterol, blood pressure, and body fat, and heart disease is the leading cause of death in women. Hormone therapy is not prescribed to prevent heart disease, but started near menopause in healthy women, current evidence does not show it raises cardiac risk and may be neutral to favorable.

What changes in the heart and blood vessels at menopause?

Estrogen has effects throughout the cardiovascular system — on blood vessel flexibility, cholesterol handling, and where the body stores fat. As estrogen falls during the transition, several risk markers tend to shift in an unfavorable direction. None of this is destiny, but it explains why midlife is an important window to pay attention to heart health.

  • LDL ("bad") cholesterol and triglycerides often rise, while HDL ("good") cholesterol may change unfavorably.
  • Blood pressure tends to increase.
  • Body fat often redistributes toward the abdomen, which is linked to higher cardiovascular risk.
  • Blood vessels can become stiffer, affecting how well they respond and relax.
The menopause transition is associated with adverse changes in lipids, body composition, and vascular function that can increase a woman's cardiovascular disease risk.
American Heart Association, Scientific Statement on Menopause and Cardiovascular Risk

Does hormone therapy help or hurt the heart?

This is one of the most misunderstood questions in menopause care, largely because of how the Women's Health Initiative was first reported in 2002. That trial's average participant was 63 — well past menopause — and the early headlines did not capture the role of timing. Later analysis pointed to what is now called the timing hypothesis: the cardiovascular effect of hormone therapy depends heavily on when it is started.

For women who initiate hormone therapy before age 60 or within 10 years of menopause onset, the data do not indicate an increased risk of coronary heart disease, and some analyses suggest a possible reduction.
The Menopause Society, 2022 Hormone Therapy Position Statement

The important nuance: hormone therapy is not approved or recommended to prevent heart disease. For a healthy woman starting near menopause for bothersome symptoms, current evidence is reassuring on the heart. For women starting many years after menopause, the balance is different. This is exactly why the decision is individualized and timing-aware, and why transdermal estradiol — which appears to carry a lower clot risk than oral — is often favored when cardiovascular factors are in play.

The timing hypothesis: cardiac risk by when hormone therapy starts
Timing of initiationCoronary heart disease signalTypical approach
Before age 60 or within 10 years of menopauseNo increased risk shown; some analyses suggest possible reductionOften reassuring for symptom-driven use
Many years after menopause (older initiation)Risk-benefit balance shifts, less reassuringMore cautious, individualized review

How can you protect your heart in midlife?

Whatever you decide about hormone therapy, the foundations of heart health do the heavy lifting. These steps have strong evidence and benefit every woman in the transition.

  • Know your numbers — blood pressure, cholesterol, and blood sugar — and review them with a clinician.
  • Aim for regular aerobic activity plus strength training most weeks.
  • Eat a heart-healthy pattern rich in vegetables, whole grains, legumes, and unsaturated fats.
  • Do not smoke, and keep alcohol moderate.
  • Treat sleep problems and chronic stress, both of which affect cardiovascular health.
Hormone therapy has both benefits and risks and is not a heart medication. If you have a history of blood clots, stroke, or heart disease, review who should not take hormone therapy — the proven heart-protective tools are blood-pressure and cholesterol management, exercise, diet, and not smoking, discussed with a licensed clinician who knows your history.

The bottom line

Menopause is a meaningful moment for heart health, both because risk markers shift and because it is a natural prompt to take stock. Hormone therapy started near menopause does not appear to raise cardiac risk in healthy women, but it is chosen for symptom relief, not heart protection. The most powerful steps for your heart are the lifestyle and screening fundamentals — and a clinician can help you put them together with the right menopause plan for you.

FAQ

Questions, answered

Cardiovascular risk tends to rise around menopause as estrogen declines, with less favorable cholesterol, higher blood pressure, and shifts in body fat. Heart disease is the leading cause of death in women, which makes midlife an important time to manage risk factors.

Feel like yourself again.

Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.